Berberine is a quaternary protoberberine isoquinoline alkaloid and a chemical found in some plants like European barberry, goldenseal, goldthread, Oregon grape, phellodendron, and tree turmeric. Berberine is a bitter-tasting and yellow-colored chemical. It is commonly supplied as salts such as berberine chloride or berberine sulfate and exists as a permanently charged cation at physiological pH, which strongly influences solubility and membrane transport. Mechanistically berberine has been shown to inhibit mitochondrial respiratory complex I leading to an increased AMP to ATP ratio and subsequent activation of AMP activated protein kinase AMPK, modulate gut microbial metabolism to produce more bioavailable reduced metabolites such as dihydroberberine, alter hepatic gene transcription to reduce gluconeogenesis, and affect cardiac electrophysiology and contractility through interactions with ion channels and autonomic tone; it might help strengthen the heartbeat, which could ben + some more technical info. Oral bioavailability is limited by P glycoprotein efflux and first pass metabolism; co administration with P glycoprotein inhibitors or use of dihydroberberine prodrugs increases systemic exposure. Clinically reported actions include improvements in glycemic control, reductions in LDL cholesterol, and effects on insulin sensitivity, but dose response and safety depend on formulation, coadministered drugs, and hepatic clearance.
Parent: Berberine Chloride / Berberine
Parent: Berberine
Parent: Berberine
Parent: Berberine
Purity and impurity profiles depend on whether the material is a crude botanical extract or an isolated API salt; isolated berberine salts used in research and nutraceuticals are typically specified at greater than 95 to 99 percent w w by HPLC, while botanical extracts can range from low single digit percent up to 50 percent or more berberine depending on standardization. Related protoberberine alkaloids that commonly occur as process or botanical related impurities include palmatine, jatrorrhizine, columbamine, berbamine, oxyberberine and canadine; individual related alkaloids in well processed isolates are typically present at trace to low percent levels often below 1 to 3 percent each, with total related alkaloids controlled to single digit percent levels in high purity material. Other impurity classes to control include residual solvents from extraction or crystallization (managed to ICH Q3C limits), inorganic residues and heavy metals (controlled to pharmacopeial or customer specified limits), and microbial endotoxins or bioburden for liquid preparations. Analytical control is normally performed with orthogonal methods such as HPLC coupled with UV or MS detection for assay and related substances, LC MS for metabolite profiling, and ICP MS for elemental impurities.
Berberine can support weight management through metabolic mechanisms rather than acting as a direct thermogenic agent; activation of AMPK reduces hepatic gluconeogenesis and increases peripheral glucose uptake, modulation of gut microbiota can alter energy harvesting, and improvements in insulin sensitivity often coincide with modest reductions in body weight and visceral fat in clinical trials. Effects are typically modest and dependent on dose, formulation, dietary context and duration of use.
Berberine is primarily metabolized in the liver and undergoes extensive Phase I and Phase II metabolism, but in controlled clinical use it is not generally associated with frequent hepatotoxicity; rare cases of elevated liver enzymes or liver injury have been reported, so monitoring hepatic function is prudent for long term use or in patients with pre existing liver disease and when coadministered with other hepatically metabolized drugs. Because berberine can inhibit certain CYP enzymes and transporters, drug interactions that alter hepatic exposure should be considered.
Berberine acts on multiple physiological systems: at the cellular level it inhibits mitochondrial complex I causing AMPK activation, at the metabolic level it reduces hepatic glucose output and improves insulin mediated glucose uptake, at the lipid level it can reduce LDL cholesterol and triglycerides via effects on LDL receptor and lipid metabolism, and at the cardiovascular level it can modify heart rate, contractility and rhythm through ion channel and autonomic modulation. It also influences gut microbiota composition and produces microbiota mediated metabolites that affect systemic pharmacology. Pharmacokinetics are characterized by low oral bioavailability and significant first pass and microbial metabolism.
In India berberine containing plants and preparations are commonly referred to by their botanical or vernacular names; Coscinium fenestratum and Berberis aristata are two berberine bearing species used in traditional systems and are often called daruharidra or daruhaldi in Sanskrit and regional languages, while isolated berberine as a chemical is typically referenced as berberine or berberine chloride in scientific and commercial contexts.
